Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
400.43
+4.11 (1.04%)
At close: Nov 4, 2026, 4:00 PM EST
395.01
-5.42 (-1.35%)
Pre-market: Nov 5, 2026, 7:47 AM EST

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,30213,2266,7304,5685,1791,449
Market Cap Growth
1.21%96.52%47.33%-11.79%257.45%-15.74%
Enterprise Value
8,69512,4625,8514,4525,0751,151
Last Close Price
400.43582.34308.57231.38290.2584.74

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
106.38191.16----
PS Ratio
6.5113.8037.36---
PB Ratio
14.8321.958.9211.2726.247.39
P/TBV Ratio
15.0122.228.9811.2726.247.39

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.0913.0032.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.560.580.160.290.250.00
Net Debt / Equity Ratio
-0.97-1.05-1.07-1.27-1.56-1.37
Net Debt / EBITDA Ratio
4.022.131.621.361.051.11
Net Debt / FCF Ratio
3.603.351.771.591.371.46
Asset Turnover
1.020.830.21---
Inventory Turnover
1.351.03----
Quick Ratio
2.623.605.795.353.103.52
Current Ratio
3.054.016.105.383.123.54
Return on Equity (ROE)
-24.82%-42.49%-80.35%-123.98%-150.12%-110.92%
Return on Assets (ROA)
-6.82%-16.30%-36.98%-47.41%-57.71%-54.09%
Return on Capital Employed (ROCE)
-15.60%-31.60%-57.00%-72.90%-119.00%-123.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.68%-2.18%-6.92%-8.18%-5.70%-16.69%
FCF Yield
-1.81%-1.44%-6.79%-7.13%-4.35%-12.71%
Buyback Yield / Dilution
13.52%-5.46%-13.83%-9.05%-3.64%-7.05%
SEC Filings: 10-K · 10-Q